Mukherjee Lab

 

Papers:

1. Raaijmakers, Marc. , Mukherjee,S (* jointly first authored), Shangqin Guo,, Siyi Zhang, Tatsuya Kobayashi, Jesse A. Schoonmaker, Benjamin L. Ebert, Fatima Al-Shahrour, Robert P. Hasserjian , Edward O. Scadden, Zinmar Aung, Marc Matza, Matthias Merkenschlager, Charles Lin, Johanna M. Rommens and Scadden, D Bone dysfunction enables myeloid dysplasia and secondary leukemia in mice. Nature (article), 852-857 (8 April 2010)

2. Mukherjee S, Raje N, Schoomaker JA, Lui JC, Hidesshima T, Wein MN, Jones DC, Vallet S, Bouxsein ML, Pozzi S, Chhetri S, Seo YD, Aronson JP, Patel C, Fulciniti M, Purton LE, Glimcher LH, Lian JB, Stein G, Anderson KC, Scadden. DT. Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice. J Clin Invest.2008 Feb;118(2):462-4.

3. Berman SD, Calo E, Landman AS, Danielian PS, Miller ES, West JC, Fonhoue BD, Caron A, Bronson R, Bouxsein ML, Mukherjee S, Lees JA. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11851-6.

4. Vallet S, Mukherjee S* (jointly first authored), Vaghela N, Santo L, Rosen E, Ikeda H, Okawa Y, Kiziltepe T, Schoonmaker J, Xie W, Hideshima T, Weller E, Bouxsein ML, Munshi NC, Anderson KC, Scadden, D Raje N. Activin A is a novel target for Myeloma bone disease, Proc Natl Acad Sci U S A. 2010, 107 (11) 5124-5129.

 

 

JCI-2008

Nature-2010

PNAS-2010

 

Books:

The Emperor of all Maladies

 

Posters:

Columbia-2010

 

Coming Soon:

Literature Review